Nurix Therapeutics, Inc. (NRIX)
25.10
-0.72
(-2.81%)
USD |
NASDAQ |
Sep 03, 14:13
Nurix Therapeutics Net Income (Annual) : -264.46M for Nov. 30, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| November 30, 2025 | -264.46M |
| November 30, 2024 | -193.57M |
| November 30, 2023 | -143.95M |
| November 30, 2022 | -180.36M |
| Date | Value |
|---|---|
| November 30, 2021 | -117.19M |
| November 30, 2020 | -43.24M |
| November 30, 2019 | -21.70M |
| November 30, 2018 | -9.428M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Monte Rosa Therapeutics, Inc. | -38.63M |
| Gilead Sciences, Inc. | 8.51B |
| TG Therapeutics, Inc. | 447.18M |
| Cue Biopharma, Inc. | -26.60M |
| Keros Therapeutics, Inc. | 87.01M |